WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2016> 32> 6

Volume: 32 Issue: 6

1. Control of patients′ condition and prevention of complications in patients with decompensated liver cirrhosis Page:1033—1035
2. Advances in staging and treatment of hepatitis B cirrhosis Page:1036—1039
3. Research advances in treatment of cirrhotic ascites Page:1069—1074
4. Current research on liver cirrhosis with portal vein thrombosis Page:1075—1078
5. Research advances in computed tomography and magnetic resonance imaging findings of cirrhotic portal hypertension Page:1079—1082
6. Coagulation disorders in patients with liver cirrhosis Page:1083—1085
7. Pathological features of liver fibrosis/cirrhosis caused by different factors Page:1086—1091
8. Selection of the diagnostic and therapeutic methods for minimal hepatic encephalopathy Page:1092—1099
9. Current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis Page:1100—1103
10. Effect of antiviral therapy on long-term prognosis of patients with decompensated hepatitis B cirrhosis Page:1104—1107
11. Therapeutic effects of entecavir and adefovir dipivoxil in hepatitis B cirrhosis patients with hepatogenous diabetes: a comparative analysis Page:1108—1111
12. Hepatic myelopathy after transjugular intrahepatic portosystemic shunt: natural course, survival analysis, and treatment Page:1112—1117
13. Influence of antiviral therapy with telbivudine on serum soluble complement receptor type 1 in patients with chronic hepatitis B or liver cirrhosis Page:1118—1120
14. Molecular mechanism in the pathogenesis of mild chronic hepatitis B based on microRNA regulation Page:1130—1134
15. Effect of stereotactic body radiotherapy versus intensity-modulated radiotherapy in primary liver cancer patients with secondary malignant tumor of vertebra Page:1135—1138
16. Clinical application of laparoscopy combined with choledochoscopy and duodenoscopy in treatment of gallstones complicated by intra- and extrahepatic bile duct stones Page:1145—1148
17. Clinical effect of primary duct closure and T-tube drainage after laparoscopic common bile duct exploration: a comparative analysis Page:1149—1151
18. Endoscopic retrograde cholangiopancreatography after Billroth-Ⅱ gastrectomy and its safety Page:1152—1154
19. Association between non-high-density lipoprotein cholesterol and nonalcoholic fatty liver disease in postmenopausal Uyghur women in Xinjiang, China Page:1155—1159
20. New advances in drug therapies for liver fibrosis Page:1183—1187
21. Research advances in diagnosis and treatment of spontaneous bacterial peritonitis Page:1188—1191
22. Research advances in the role of aquaporins in liver fibrosis and liver cirrhosis Page:1192—1195
23. Advances in basic research on mesenchymal stem cells and its clinical application in liver cirrhosis Page:1196—1198
24. Direction and progress in research and development of anti-HBV drugs Page:1199—1103
25. Research advances in blocking mother-to-child transmission of hepatitis B virus and hepatitis C virus Page:1207—1211
26. Basic research and therapeutic strategies for multinodular hepatocellular carcinoma Page:1212—1215
27. Current status of research on transcatheter arterial chemoembolization in treatment of colorectal cancer liver metastasis Page:1216—1219
28. Immunological characteristics of tumor antigen specific T cells and their possible mechanisms in hepatocellular carcinoma Page:1220—1224
29. Research advances in mechanisms and intervention of hepatic ischemia-reperfusion injury Page:1225—1229
30. Role of follicular helper T cells in development and progression of liver diseases Page:1230—1234

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.